menu search

NUS / Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin: Attractive Valuation Trumps Near-Term Risks
Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance for 2023. The company reported resilient Q2 earnings with sustained gross margins and in line EPS supported by strong growth in China. Despite the challenges, the valuation appears attractive at just 8.7x Fwd PE and a forward dividend yield of 6.7%. Read More
Posted: Sep 12 2023, 13:08
Author Name: Seeking Alpha
Views: 112598

NUS News  

Nu Skin Enterprises, Inc. (NUS) Q3 2023 Earnings Call Transcript

By Seeking Alpha
November 1, 2023

Nu Skin Enterprises, Inc. (NUS) Q3 2023 Earnings Call Transcript

Nu Skin Enterprises, Inc. (NYSE:NUS ) Q3 2023 Earnings Conference Call November 1, 2023 5:00 PM ET Company Participants Scott Pond – Vice President- more_horizontal

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

By Zacks Investment Research
October 30, 2023

Why Nu Skin (NUS) Could Beat Earnings Estimates Again

Nu Skin (NUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i more_horizontal

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

By Zacks Investment Research
October 10, 2023

Nu Vision 2025 Strategy Aids Nu Skin (NUS), High Costs Hurt

Nu Skin (NUS) is on track with its Nu Vision 2025 strategy. However, the company is operating amid macroeconomic hurdles. more_horizontal

Nu Skin Enterprises to Announce Third Quarter 2023 Financial Results

By PRNewsWire
October 3, 2023

Nu Skin Enterprises to Announce Third Quarter 2023 Financial Results

PROVO, Utah , Oct. 3, 2023 /PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release third quarter 2023 results after the more_horizontal

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

By Zacks Investment Research
September 21, 2023

Nu Skin (NUS) Down More Than 25% in 3 Months: Here's Why

Nu Skin (NUS) is witnessing continued macroeconomic hurdles and an inflationary environment. The company is also battling unfavorable currency movemen more_horizontal

Nu Skin: Attractive Valuation Trumps Near-Term Risks

By Seeking Alpha
September 12, 2023

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Nu Skin Enterprises had been impacted by COVID-19 initially and tough macro-environment recently, leading to a decline in sales and lowered guidance f more_horizontal

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

By Zacks Investment Research
September 6, 2023

Nu Skin (NUS) Appears Dull on High Cost & Currency Headwinds

Nu Skin's (NUS) margins have been contracting year over year for a while now. The company is also battling unfavorable currency headwinds. more_horizontal

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

By Zacks Investment Research
August 29, 2023

Nu Skin (NUS) Down More Than 30% in 3 Months: Here's Why

Nu Skin (NUS) is battling continued macroeconomic hurdles and related price increases, affecting specific key markets, leading to a slowdown in consum more_horizontal


Search within

Pages Search Results: